{"id":"https://openalex.org/W1993558831","doi":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","title":"The Effect of Dexamethasone on the Pharmacokinetics of Triazolam","display_name":"The Effect of Dexamethasone on the Pharmacokinetics of Triazolam","alternate_titles":[],"publication_year":1998,"publication_date":"1998-09-01","ids":{"openalex":"https://openalex.org/W1993558831","doi":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","mag":"1993558831","pmid":"https://pubmed.ncbi.nlm.nih.gov/9783333"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0773.1998.tb01457.x","doi":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0773.1998.tb01457.x","source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology &amp; Toxicology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1993558831"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0773.1998.tb01457.x","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109274630","display_name":"Kirsti Villikka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Kirsti Villikka","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109328662","display_name":"Kari T. Kivist\u00f6","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kari T. Kivist\u00f6","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089475081","display_name":"Pertti J. Neuvonen","orcid":"https://orcid.org/0000-0003-3631-9411","observed_orcids":["https://orcid.org/0000-0003-3631-9411"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pertti J. Neuvonen","raw_affiliation_strings":["Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109274630"],"corresponding_institution_ids":["https://openalex.org/I133731052"],"apc_list":null,"apc_paid":null,"fwci":0.657,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.61538462,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"83","issue":"3","first_page":"135","last_page":"138"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/triazolam","display_name":"triazolam","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cyp3a4-induction","display_name":"CYP3A4 induction","score":0.8730000257492065},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.7099999785423279},{"id":"https://openalex.org/keywords/glucocorticoids","display_name":"glucocorticoids","score":0.7049999833106995},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8199999928474426},{"id":"https://openalex.org/keywords/psychomotor-effects","display_name":"psychomotor effects","score":0.7770000100135803},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2779738154","wikidata":"https://www.wikidata.org/wiki/Q412143","display_name":"Triazolam","level":4,"score":0.9816110134124756},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8632482290267944},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6629993319511414},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6435518264770508},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5694937705993652},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49822568893432617},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.45417189598083496},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4029726982116699},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3653518855571747},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3604215681552887},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3159882426261902},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.25560033321380615},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000759","descriptor_name":"Adjuvants, Anesthesia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000759","descriptor_name":"Adjuvants, Anesthesia","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012016","descriptor_name":"Reference Values","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014229","descriptor_name":"Triazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0773.1998.tb01457.x","doi":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0773.1998.tb01457.x","source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology &amp; Toxicology","raw_type":"journal-article"},{"id":"pmid:9783333","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9783333","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology & toxicology","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1111/j.1600-0773.1998.tb01457.x","doi":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1600-0773.1998.tb01457.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1600-0773.1998.tb01457.x","source":{"id":"https://openalex.org/S62051601","display_name":"Pharmacology & Toxicology","issn_l":"0901-9928","issn":["0901-9928","1600-0773"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology &amp; Toxicology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9074000120162964}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310467","display_name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","ror":"https://ror.org/020cpqb94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1993558831.pdf","grobid_xml":"https://content.openalex.org/works/W1993558831.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1925533802","https://openalex.org/W1958017720","https://openalex.org/W1972930816","https://openalex.org/W1984175249","https://openalex.org/W1984337477","https://openalex.org/W1996485240","https://openalex.org/W1999363883","https://openalex.org/W2003485965","https://openalex.org/W2014181397","https://openalex.org/W2049457605","https://openalex.org/W2058385006","https://openalex.org/W2094764170","https://openalex.org/W2096266931","https://openalex.org/W2112381649","https://openalex.org/W2138644435","https://openalex.org/W2147274916","https://openalex.org/W2309607074"],"related_works":["https://openalex.org/W2016922039","https://openalex.org/W2026436152","https://openalex.org/W2162946847","https://openalex.org/W1981797192","https://openalex.org/W7082647232","https://openalex.org/W4399634301","https://openalex.org/W2419454552","https://openalex.org/W2166591997","https://openalex.org/W2356228428","https://openalex.org/W2406894650"],"abstract_inverted_index":{"The":[0,83,125],"effects":[1,63,77,137,148,179],"of":[2,5,9,16,64,81,138,154,165,173,180,185],"short-term":[3],"use":[4,164],"a":[6,24,44,169],"small":[7,147],"dose":[8],"dexamethasone":[10,40,99,144,166,181],"on":[11,78,149,177,182],"the":[12,17,50,79,88,98,103,136,141,150,157,178,183],"pharmacokinetics":[13,80,151,184],"and":[14,62,152],"pharmacodynamics":[15,153],"CYP3A4":[18,186],"substrate,":[19],"triazolam,":[20],"were":[21,35,66],"examined.":[22],"In":[23],"randomized,":[25],"double-blind":[26],"cross-over":[27],"study":[28],"with":[29],"two":[30],"phases,":[31],"ten":[32],"healthy":[33],"volunteers":[34],"given":[36],"either":[37],"1.5":[38],"mg":[39,54],"or":[41,162],"placebo":[42,104],"once":[43],"day":[45],"for":[46,68],"4":[47],"days.":[48],"On":[49],"5th":[51],"day,":[52],"0.5":[53],"triazolam":[55,60,65,90,139,155],"was":[56],"administered":[57],"orally.":[58],"Plasma":[59],"concentrations":[61],"measured":[67],"10":[69],"hr.":[70],"Dexamethasone":[71],"did":[72,130],"not":[73,131],"have":[74],"statistically":[75],"significant":[76,133],"triazolam.":[82],"mean":[84],"total":[85],"area":[86],"under":[87],"plasma":[89],"concentration-time":[91],"curve":[92],"was,":[93],"however,":[94],"19%":[95],"smaller":[96],"during":[97,102],"phase":[100,105],"than":[101],"(11.4":[106],"+/-":[107,114,120],"5.7":[108],"ng":[109,116],"ml-1":[110,117],"hr":[111,118],"versus":[112],"14.1":[113],"8.8":[115],"(mean":[119],"S.D.);":[121],"P":[122],"=":[123],"0.09).":[124],"four":[126],"psychomotor":[127],"tests":[128],"employed":[129],"show":[132],"differences":[134],"in":[135,156,188],"between":[140],"phases.":[142],"Although":[143],"had":[145],"only":[146],"present":[158],"study,":[159],"higher":[160],"doses":[161],"prolonged":[163],"might":[167],"cause":[168],"more":[170],"pronounced":[171],"induction":[172],"CYP3A4.":[174],"Further":[175],"studies":[176],"substrates":[187],"man":[189],"are":[190],"needed.":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1993558831","counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
